OQROGet OQRO Pro
Politician trade (House)

Abbott Laboratories (ABT)Rep. Mike Kelly (PA16) disclosed a sale $1K–$15K

Rep. Mike Kelly (PA16) disclosed a sale of Abbott Laboratories in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
26 days
Disclosure lag
Traded
Jul 17, 2026
Disclosed
Aug 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
  2. Apr 16, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
  3. May 7, 2026Insider · Their largest buy since 2019Director purchased ~$174K of ABT shares in the open market
  4. May 12, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  5. May 15, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  6. May 27, 2026Government · Federal Register noticeDrugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation 7661
  7. May 27, 2026CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  8. Jun 12, 2026Congress · 1 personMembers of Congress: 2 purchases
  9. Jun 16, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  10. Jun 17, 2026FDAFDA device clearance: Amplatzer TorqVue Exchange System
  11. Jul 2, 2026FDAFDA device clearance: Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP Catheter
  12. Jul 7, 2026Government · Federal Register proposed ruleMedicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
  13. Jul 8, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  14. Jul 14, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
  15. Jul 15, 2026FDAFDA device clearance: EnSite™ X EP System
  16. Jul 16, 2026Company filing · Form 8-K · ResultsReported its results
  17. Jul 17, 2026 · this disclosureCongressDisclosed sale of ABT — reported range $1,001 - $15,000

What came next

  1. Jul 30, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  2. Aug 6, 2026Government · Federal Register noticeForeign-Trade Zone (FTZ) 39, Notification of Proposed Production Activity; Abbott Laboratories; (Diagnostic Medical Devices); Irving, Texas
  3. Aug 11, 2026InsiderOfficer sold ~$643K of ABT shares in the open market
  4. Aug 25, 2026Insider · 1 personInsiders: 2 sales (~$46.2M)
  5. Sep 2, 2026InsiderOfficer sold ~$3K of ABT shares in the open market
  6. Sep 17, 2026FDAFDA device clearance: EnSite™ X EP System
  7. Sep 23, 2026FDAFDA device clearance: Anti-HCV Next
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 82 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. Mike Kelly (PA16)

The full history of Rep. Mike Kelly (PA16) is on the profile page.

How this filing works

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data